Upload Image (Max 20MB per Image)
The US FDA has granted fast track review to Glenveigh Medical’s Digoxin Immune Fab (DIF), which is being developed as severe preeclampsia therapy. Glenveigh Medical founder and chairman Dr. David Adair said DIF is taking ...
Tags: FDA, severe preeclampsia therapy, digoxin immune fab